These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
208 related articles for article (PubMed ID: 23145507)
1. Time trends in chemotherapy (administration and costs) and relative survival in stage III colon cancer patients - a large population-based study from 1990 to 2008. van den Broek CB; Bastiaannet E; Dekker JW; Portielje JE; de Craen AJ; Elferink MA; van de Velde CJ; Liefers GJ; Kapiteijn E Acta Oncol; 2013 Jun; 52(5):941-9. PubMed ID: 23145507 [TBL] [Abstract][Full Text] [Related]
2. The survival gap between middle-aged and elderly colon cancer patients. Time trends in treatment and survival. van den Broek CB; Dekker JW; Bastiaannet E; Krijnen P; de Craen AJ; Tollenaar RA; van de Velde CJ; Liefers GJ Eur J Surg Oncol; 2011 Oct; 37(10):904-12. PubMed ID: 21784608 [TBL] [Abstract][Full Text] [Related]
3. Patterns of adjuvant chemotherapy for stage II and III colon cancer in France and Italy. Bouvier AM; Minicozzi P; Grosclaude P; Bouvier V; Faivre J; Sant M Dig Liver Dis; 2013 Aug; 45(8):687-91. PubMed ID: 23428703 [TBL] [Abstract][Full Text] [Related]
4. Adjuvant chemotherapy in stage III colon cancer: guideline implementation, patterns of use and outcomes in daily practice in The Netherlands. van Gils CW; Koopman M; Mol L; Redekop WK; Uyl-de Groot CA; Punt CJ Acta Oncol; 2012 Jan; 51(1):57-64. PubMed ID: 22122695 [TBL] [Abstract][Full Text] [Related]
5. Conventional adverse features do not predict response to adjuvant chemotherapy in stage II colon cancer. Peng SL; Thomas M; Ruszkiewicz A; Hunter A; Lawrence M; Moore J ANZ J Surg; 2014 Nov; 84(11):837-41. PubMed ID: 24224835 [TBL] [Abstract][Full Text] [Related]
6. Omission of Adjuvant Chemotherapy Is Associated With Increased Mortality in Patients With T3N0 Colon Cancer With Inadequate Lymph Node Harvest. Wells KO; Hawkins AT; Krishnamurthy DM; Dharmarajan S; Glasgow SC; Hunt SR; Mutch MG; Wise P; Silviera ML Dis Colon Rectum; 2017 Jan; 60(1):15-21. PubMed ID: 27926553 [TBL] [Abstract][Full Text] [Related]
7. The efficacy of oral tegafur-uracil as maintenance therapy following intravenous 5-fluorouracil chemotherapy in stage III colon cancer. Hong KD; Lee SI; Moon HY Hepatogastroenterology; 2012; 59(113):104-7. PubMed ID: 22251527 [TBL] [Abstract][Full Text] [Related]
8. Overtreatment of young adults with colon cancer: more intense treatments with unmatched survival gains. Kneuertz PJ; Chang GJ; Hu CY; Rodriguez-Bigas MA; Eng C; Vilar E; Skibber JM; Feig BW; Cormier JN; You YN JAMA Surg; 2015 May; 150(5):402-9. PubMed ID: 25806815 [TBL] [Abstract][Full Text] [Related]
9. Practical outcome of adjuvant FOLFOX4 chemotherapy in elderly patients with stage III colon cancer: single-center study in Korea. Kim JY; Kim YJ; Lee KW; Lee JS; Kim DW; Kang SB; Lee HS; Jang NY; Kim JS; Kim JH Jpn J Clin Oncol; 2013 Feb; 43(2):132-8. PubMed ID: 23204187 [TBL] [Abstract][Full Text] [Related]
10. Effect of age on survival benefit of adjuvant chemotherapy in elderly patients with Stage III colon cancer. Zuckerman IH; Rapp T; Onukwugha E; Davidoff A; Choti MA; Gardner J; Seal B; Mullins CD J Am Geriatr Soc; 2009 Aug; 57(8):1403-10. PubMed ID: 19563521 [TBL] [Abstract][Full Text] [Related]
11. A population-based study of adjuvant chemotherapy for stage-II and -III colon cancers. Phelip JM; Molinié F; Delafosse P; Launoy G; Trétarre B; Bara S; Buémi A; Velten M; Danzon A; Ganry O; Bouvier AM; Grosclaude P; Faivre J Gastroenterol Clin Biol; 2010 Feb; 34(2):144-9. PubMed ID: 20079591 [TBL] [Abstract][Full Text] [Related]
12. Adjuvant chemotherapy is not associated with improved survival for all high-risk factors in stage II colon cancer. Verhoeff SR; van Erning FN; Lemmens VE; de Wilt JH; Pruijt JF Int J Cancer; 2016 Jul; 139(1):187-93. PubMed ID: 26914273 [TBL] [Abstract][Full Text] [Related]
13. Adjuvant chemotherapy for stage III colon cancer in the oldest old: results beyond clinical guidelines. Abraham A; Habermann EB; Rothenberger DA; Kwaan M; Weinberg AD; Parsons HM; Gupta P; Al-Refaie WB Cancer; 2013 Jan; 119(2):395-403. PubMed ID: 22806931 [TBL] [Abstract][Full Text] [Related]
14. Colorectal signet-ring cell carcinoma: benefit from adjuvant chemotherapy but a poor prognostic factor. Hugen N; Verhoeven RH; Lemmens VE; van Aart CJ; Elferink MA; Radema SA; Nagtegaal ID; de Wilt JH Int J Cancer; 2015 Jan; 136(2):333-9. PubMed ID: 24841868 [TBL] [Abstract][Full Text] [Related]
15. Adjuvant chemotherapy and relative survival of patients with stage II colon cancer - A EURECCA international comparison between the Netherlands, Denmark, Sweden, England, Ireland, Belgium, and Lithuania. Breugom AJ; Bastiaannet E; Boelens PG; Iversen LH; Martling A; Johansson R; Evans T; Lawton S; O'Brien KM; Van Eycken E; Janciauskiene R; Liefers GJ; Cervantes A; Lemmens VE; van de Velde CJ Eur J Cancer; 2016 Aug; 63():110-7. PubMed ID: 27299663 [TBL] [Abstract][Full Text] [Related]
16. Trends in colorectal cancer in the south of the Netherlands 1975-2007: rectal cancer survival levels with colon cancer survival. Lemmens V; van Steenbergen L; Janssen-Heijnen M; Martijn H; Rutten H; Coebergh JW Acta Oncol; 2010 Aug; 49(6):784-96. PubMed ID: 20429731 [TBL] [Abstract][Full Text] [Related]
17. Estimating the adjuvant chemotherapy effect in elderly stage II and III colon cancer patients in an observational study. Kim KY; Cha IH; Ahn JB; Kim NK; Rha SY; Chung HC; Roh JK; Shin SJ J Surg Oncol; 2013 May; 107(6):613-8. PubMed ID: 23592499 [TBL] [Abstract][Full Text] [Related]
18. A prospective randomised phase III trial of adjuvant chemotherapy with 5-fluorouracil and leucovorin in patients with stage II colon cancer. Schippinger W; Samonigg H; Schaberl-Moser R; Greil R; Thödtmann R; Tschmelitsch J; Jagoditsch M; Steger GG; Jakesz R; Herbst F; Hofbauer F; Rabl H; Wohlmuth P; Gnant M; Thaler J; Br J Cancer; 2007 Oct; 97(8):1021-7. PubMed ID: 17895886 [TBL] [Abstract][Full Text] [Related]
19. Does delay of adjuvant chemotherapy impact survival in patients with resected stage II and III colon adenocarcinoma? Bayraktar UD; Chen E; Bayraktar S; Sands LR; Marchetti F; Montero AJ; Rocha-Lima CM Cancer; 2011 Jun; 117(11):2364-70. PubMed ID: 24048783 [TBL] [Abstract][Full Text] [Related]